J Neurol Surg B Skull Base 2021; 82(05): 491-499
DOI: 10.1055/s-0040-1714110
Original Article

Clinical and Imaging Response to Trigeminal Schwannoma Radiosurgery: A Retrospective Analysis of a 28-Year Experience

Ajay Niranjan
1   Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
,
Sudesh S. Raju
2   Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
,
Hideyuki Kano
1   Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
,
John C. Flickinger
3   Department of Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
,
Lawrence Dade Lunsford
1   Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
› Author Affiliations

Abstract

Objective The purpose of this study was to evaluate long-term clinical outcomes and tumor control after stereotactic radiosurgery (SRS) for trigeminal schwannoma (TS).

Methods During a 28-year period (1989–2017), 50 patients underwent SRS for TS. The median patient age was 51 years (range: 15–87 years). A total of 17 patients had a previous tumor resection: 10 had a single procedure, 5 had two procedures, and 2 had three procedures. The median and mean times between tumor resection and SRS were 12 and 24 months (range: 1–90 months), respectively. Four patients had neurofibromatosis II (NF2). Based on location, tumors were classified as root type (7), ganglion type (22), or dumbbell type (21). The median radiosurgery target volume was 3.4 cm3 (range: 0.10–18 cm3), median target dose was 14 Gy (range: 12–20 Gy), and the median number of isocenters was 6 (range: 1–15). The median and mean times to last follow-up was 36.9 and 55.2 months (range: 4–205 months), respectively. Eighteen patients (36%) had longer than 5-year follow-up, and seven patients (14%) had longer than 10-year follow-up.

Results The tumor control rate was 92% and the clinical improvement or stabilization rate was 94%. After SRS, the rates of progression free survival (PFS) at 1, 5, and 10 years were 98, 84, and 84%, respectively. Factors associated with improved PFS were female sex (p = 0.014) and smaller tumor volume (p = 0.022). In this series, we did not find that tumor type (root, ganglion, and dumbbell) had a statistically significant correlation to PFS. Forty-seven patients had neurological signs or symptoms at presentation. At last follow-up, neurological signs or symptoms improved in 22/47 (47%), remained unchanged in 24/50 (48%), and worsened due to tumor progression in 3/50 (6%). One patient (2%) developed temporary symptomatic adverse radiation effect (ARE) and three additional patients (6%) had transient imaging evidence of peritumoral reactive edema but no new symptoms.

Conclusion As a single outpatient procedure, SRS was associated with long-term freedom from additional management in 84% of patients. Nearly half the treated patients experienced improvement in neurological symptoms or signs.



Publication History

Received: 24 March 2020

Accepted: 17 May 2020

Article published online:
14 August 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Kano H, Niranjan A, Kondziolka D, Flickinger JC, Dade Lunsford L. Stereotactic radiosurgery for trigeminal schwannoma: tumor control and functional preservation Clinical article. J Neurosurg 2009; 110 (03) 553-558
  • 2 Niranjan A, Barnett S, Anand V, Agazzi S. Multimodality management of trigeminal schwannomas. J Neurol Surg B Skull Base 2016; 77 (04) 371-378
  • 3 Chen LF, Yang Y, Yu XG. et al. Operative management of trigeminal neuromas: an analysis of a surgical experience with 55 cases. Acta Neurochir (Wien) 2014; 156 (06) 1105-1114
  • 4 Fukaya R, Yoshida K, Ohira T, Kawase T. Trigeminal schwannomas: experience with 57 cases and a review of the literature. Neurosurg Rev 2010; 34 (02) 159-171
  • 5 Goel A, Muzumdar D, Raman C. Trigeminal neuroma: analysis of surgical experience with 73 cases. Neurosurgery 2003; 52 (04) 783-790 , discussion 790
  • 6 Jeong SK, Lee EJ, Hue YH, Cho YH, Kim JH, Kim CJ. A suggestion of modified classification of trigeminal schwannomas according to location, shape, and extension. Brain Tumor Res Treat 2014; 2 (02) 62-68
  • 7 Konovalov AN, Spallone A, Mukhamedjanov DJ, Tcherekajev VA, Makhmudov UB. Trigeminal neurinomas. A series of 111 surgical cases from a single institution. Acta Neurochir (Wien) 1996; 138 (09) 1027-1035
  • 8 McCormick PC, Bello JA, Post KD. Trigeminal schwannoma. Surgical series of 14 cases with review of the literature. J Neurosurg 1988; 69 (06) 850-860
  • 9 Pamir MN, Peker S, Bayrakli F, Kiliç T, Ozek MM. Surgical treatment of trigeminal schwannomas. Neurosurg Rev 2007; 30 (04) 329-337 , discussion 337
  • 10 Pollack IF, Sekhar LN, Jannetta PJ, Janecka IP. Neurilemomas of the trigeminal nerve. J Neurosurg 1989; 70 (05) 737-745
  • 11 Samii M, Alimohamadi M, Gerganov V. Endoscope-assisted retrosigmoid intradural suprameatal approach for surgical treatment of trigeminal schwannomas. Neurosurgery 2014; 10 (Suppl. 04) 565-575 , discussion 575
  • 12 Wanibuchi M, Fukushima T, Zomordi AR, Nonaka Y, Friedman AH. Trigeminal schwannomas: skull base approaches and operative results in 105 patients. Neurosurgery 2012;70(01), suppl operative ):132–143, discussion 143–144
  • 13 Yoshida K, Kawase T. Trigeminal neurinomas extending into multiple fossae: surgical methods and review of the literature. J Neurosurg 1999; 91 (02) 202-211
  • 14 Hasegawa T, Kato T, Iizuka H, Kida Y. Long-term results for trigeminal schwannomas treated with gamma knife surgery. Int J Radiat Oncol Biol Phys 2013; 87 (05) 1115-1121
  • 15 Hasegawa T, Kida Y, Yoshimoto M, Koike J. Trigeminal schwannomas: results of gamma knife surgery in 37 cases. J Neurosurg 2007; 106 (01) 18-23
  • 16 Huang CF, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for trigeminal schwannomas. Neurosurgery 1999; 45 (01) 11-16 , discussion 16
  • 17 Nettel B, Niranjan A, Martin JJ. et al. Gamma knife radiosurgery for trigeminal schwannomas. Surg Neurol 2004; 62 (05) 435-444 , discussion 444–446
  • 18 Pan L, Wang EM, Zhang N. et al. Long-term results of Leksell gamma knife surgery for trigeminal schwannomas. J Neurosurg 2005; 102 (suppl): 220-224
  • 19 Peker S, Bayrakli F, Kiliç T, Pamir MN. Gamma-knife radiosurgery in the treatment of trigeminal schwannomas. Acta Neurochir (Wien) 2007; 149 (11) 1133-1137 , discussion 1137
  • 20 Phi JH, Paek SH, Chung HT. et al. Gamma Knife surgery and trigeminal schwannoma: is it possible to preserve cranial nerve function?. J Neurosurg 2007; 107 (04) 727-732
  • 21 Sheehan J, Yen CP, Arkha Y, Schlesinger D, Steiner L. Gamma knife surgery for trigeminal schwannoma. J Neurosurg 2007; 106 (05) 839-845
  • 22 Sun J, Zhang J, Yu X. et al. Stereotactic radiosurgery for trigeminal schwannoma: a clinical retrospective study in 52 cases. Stereotact Funct Neurosurg 2013; 91 (04) 236-242
  • 23 Sun S, Liu A, Wang C, Luo B, Wang M. Clinical analysis of Gamma Knife surgery for trigeminal schwannomas. J Neurosurg 2006; 105 (suppl): 144-148
  • 24 Yianni J, Dinca EB, Rowe J, Radatz M, Kemeny AA. Stereotactic radiosurgery for trigeminal schwannomas. Acta Neurochir (Wien) 2012; 154 (02) 277-283
  • 25 Snyder MH, Shepard MJ, Chen CJ, Sheehan JP. Stereotactic radiosurgery for trigeminal schwannomas: a 28-year single-center experience and review of the literature. World Neurosurg 2018; 119: e874-e881
  • 26 Samii M, Migliori MM, Tatagiba M, Babu R. Surgical treatment of trigeminal schwannomas. J Neurosurg 1995; 82 (05) 711-718
  • 27 Al-Mefty O, Ayoubi S, Gaber E. Trigeminal schwannomas: removal of dumbbell-shaped tumors through the expanded Meckel cave and outcomes of cranial nerve function. J Neurosurg 2002; 96 (03) 453-463